Adjustments in FIP Treatment Dosing and Duration

September 2025

In today’s VETgirl online veterinary continuing education podcast, we’re diving into a recent study that may reshape how we manage feline infectious peritonitis (FIP), especially  around treatment dosing and duration. With growing success using antiviral therapy for this once considered “universally fatal” disease, we now have the opportunity to refine our protocols based on real-world outcomes. So today we are reviewing the exciting findings of this article by Kamiyoshi et al entitled “High-dose induction therapy and treatment termination criteria for feline infectious peritonitis with remdesivir, GS-441524 and adjunctive mefloquine: 46 cases (2023).”

References:
Kamiyoshi T, Kamiyoshi N, Jintake C. High-dose induction therapy and treatment termination criteria for feline infectious peritonitis with remdesivir, GS-441524 and adjunctive mefloquine: 46 cases (2023). J Small Anim Pract. 2025 Sep;66(9):617-626. 

Not a VETgirl ELITE member? Get your learning on with the #1 veterinary CE resource – clinically relevant, practical, and accessible 24/7 on your own time! Don’t miss out – click HERE to check out your options, including our new  14-day, no-commitment ELITE Trial.

Only VETgirl members can leave comments. Sign In or Join VETgirl now!